DEBEL MARLENE (CIK 1770295) reported 9 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-02). Recent activity: Sell MET (4,030 shares), Buy MET (10,600 shares), Buy MET (10,712 shares), Sell MET (21,312 shares), Sell MET (4,133 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-02 | METLIFE INC (MET) | EVP & Chief Risk Officer | Sell | 4,030 | $383,535 |
| 2026-06-03 | METLIFE INC (MET) | EVP & Chief Risk Officer | Buy | 10,600 | $496,610 |
| 2026-06-03 | METLIFE INC (MET) | EVP & Chief Risk Officer | Buy | 10,712 | $487,396 |
| 2026-06-03 | METLIFE INC (MET) | EVP & Chief Risk Officer | Sell | 21,312 | $1.7M |
| 2026-03-04 | METLIFE INC (MET) | EVP & Chief Risk Officer | Sell | 4,133 | $302,701 |
| 2026-02-26 | METLIFE INC (MET) | EVP & Chief Risk Officer | Buy | 15,132 | $0 |
| 2026-02-26 | METLIFE INC (MET) | EVP & Chief Risk Officer | Buy | 14,870 | $0 |
| 2026-02-26 | METLIFE INC (MET) | EVP & Chief Risk Officer | Sell | 5,624 | $423,712 |
| 2026-02-23 | RAYMOND JAMES FINANCIAL INC (RJF) | Director | Buy | 1,253 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-02